- Home
- CLLS vs TSE Comparison
CLLS vs TSE Comparison
Compare CLLS & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- TSE
- Stock Information
- Founded
- CLLS 1999
- TSE 2010
- Country
- CLLS France
- TSE United States
- Employees
- CLLS N/A
- TSE N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- TSE Major Chemicals
- Sector
- CLLS Health Care
- TSE Industrials
- Exchange
- CLLS Nasdaq
- TSE Nasdaq
- Market Cap
- CLLS 148.1M
- TSE 151.9M
- IPO Year
- CLLS 2007
- TSE 2014
- Fundamental
- Price
- CLLS $1.32
- TSE $3.77
- Analyst Decision
- CLLS Buy
- TSE
- Analyst Count
- CLLS 3
- TSE 0
- Target Price
- CLLS $7.00
- TSE N/A
- AVG Volume (30 Days)
- CLLS 839.3K
- TSE 346.8K
- Earning Date
- CLLS 03-13-2025
- TSE 05-07-2025
- Dividend Yield
- CLLS N/A
- TSE 1.06%
- EPS Growth
- CLLS N/A
- TSE N/A
- EPS
- CLLS N/A
- TSE N/A
- Revenue
- CLLS $49,217,000.00
- TSE $3,513,200,000.00
- Revenue This Year
- CLLS $1.26
- TSE $5.72
- Revenue Next Year
- CLLS N/A
- TSE $3.80
- P/E Ratio
- CLLS N/A
- TSE N/A
- Revenue Growth
- CLLS 435.38
- TSE N/A
- 52 Week Low
- CLLS $1.14
- TSE $1.94
- 52 Week High
- CLLS $3.38
- TSE $7.05
- Technical
- Relative Strength Index (RSI)
- CLLS 49.18
- TSE 38.77
- Support Level
- CLLS $1.16
- TSE $3.51
- Resistance Level
- CLLS $1.35
- TSE $4.32
- Average True Range (ATR)
- CLLS 0.07
- TSE 0.30
- MACD
- CLLS 0.01
- TSE -0.05
- Stochastic Oscillator
- CLLS 69.23
- TSE 25.24
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.